Compare Edwards Lifesciences Corporation Common Stock (EW) vs W W Grainger Inc (GWW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs W W Grainger Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while W W Grainger Inc trades at $1,269.13 (market cap $59.51B). The key difference: W W Grainger Inc is the larger of the two by market cap, and W W Grainger Inc pays a 0.79% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | GWW | |
|---|---|---|
Market Cap | $49.44B | $59.51B |
Volume | 3,508,027 | 237,326 |
Sector | Health | Industrials |
52-Week High | $95.18 | $1.40K |
52-Week Low | $72.65 | $918.18 |
Enterprise Value | $45.90B | $61.72B |
Typical Hold Time | — | 25 Days |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GWW trades at $1,263.51, down 0.94% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth to $18.8B in 2026 and a net income margin of 9.92%. Recent news highlights Grainger's acquisition of technology assets and expansion with a new distribution center, reinforcing its market position.
The outlook is mixed: analyst consensus is a 'Hold' with a $1,310 price target, indicating modest upside. Risks include competitive pressures and economic sensitivity, but solid profitability and institutional buying support long-term value. Investors should weigh steady fundamentals against near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
